Monocyte chemotactic protein-1 level in the aqueous humour as a prognostic factor for the outcome of trabeculectomy

Clinical and Experimental Ophthalmology

Volumn 42, Issue 4, 2014, Pages 334-341

  Inoue, Toshihiro ^a   Kawaji, Takahiro ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Aqueous humour; Glaucoma; MCP 1; Multiplex immunoassay; Trabeculectomy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; INCISION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PHAKIC GLAUCOMA; PROGNOSIS; PSEUDOEXFOLIATION; PSEUDOPHAKIC GLAUCOMA; RETROSPECTIVE STUDY; RISK FACTOR; TRABECULECTOMY;

AQUEOUS HUMOUR; GLAUCOMA; MCP-1; MULTIPLEX IMMUNOASSAY; TRABECULECTOMY;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CHEMOKINE CCL2; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; IMMUNOASSAY; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PSEUDOPHAKIA; RETROSPECTIVE STUDIES; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 84901691754     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12204     Document Type: Article

References (33)

1. Picht G, Grehn F. Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol 1998; 9: 2-8.
2. Cantor LB, Mantravadi A, WuDunn D, Swamynathan K, Cortes A. Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana Bleb Appearance Grading Scale. J Glaucoma 2003; 12: 266-271.
3. Wells AP, Crowston JG, Marks J etal. A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma 2004; 13: 454-460.
4. Wells AP, Ashraff NN, Hall RC, Purdie G. Comparison of two clinical Bleb grading systems. Ophthalmology 2006; 113: 77-83.
5. Smith M, Chipman ML, Trope GE, Buys YM. Correlation between the Indiana Bleb Appearance Grading Scale and intraocular pressure after phacotrabeculectomy. J Glaucoma 2009; 18: 217-219.
6. Mills KB. Trabeculectomy: a retrospective long-term follow-up of 444 cases. Br J Ophthalmol 1981; 65: 790-795.
7. Allen RC, Bellows AR, Hutchinson BT, Murphy SD. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 1982; 89: 1181-1187.
8. Katz LJ, Spaeth GL. Surgical management of the secondary glaucomas: part I. Ophthalmic Surg 1987; 18: 826-834.
9. Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 2009; 147: 912-918, 918 e911.
10. Takihara Y, Inatani M, Seto T etal. Trabeculectomy with mitomycin for open-angle glaucoma in phakic vs pseudophakic eyes after phacoemulsification. Arch Ophthalmol 2011; 129: 152-157.
11. Law SK, Shih K, Tran DH, Coleman AL, Caprioli J. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. Am J Ophthalmol 2009; 148: 685-695 e681.
12. Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 1999; 128: 434-439.
13. Inoue T, Kawaji T, Inatani M, Kameda T, Yoshimura N, Tanihara H. Simultaneous increases in multiple proinflammatory cytokines in the aqueous humor in pseudophakic glaucomatous eyes. J Cataract Refract Surg 2012; 38: 1389-1397.
14. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol 2001; 2: 102-107.
15. Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci (Lond) 2009; 117: 95-109.
16. Rose CE Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003; 10: 273-288.
17. Fornoni A, Ijaz A, Tejada T, Lenz O. Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 2008; 4: 10-17.
18. CAT-152 0102 Trabeculectomy Study Group, Khaw P, Grehn F, Holló G etal. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 2007; 114: 1822-1830.
19. Cordeiro MF, Chang L, Lim KS etal. Modulating conjunctival wound healing. Eye (Lond) 2000; 14: 536-547.
20. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991; 109: 1693-1698.
21. Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 2005; 3: 63-68.
22. Veyssier-Belot C, Cacoub P. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension. Cardiovasc Res 1999; 44: 274-282.
23. Grande MT, Lopez-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009; 5: 319-328.
24. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000; 35: 665-672.
25. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 1994; 59: 723-727.
26. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol 2001; 239: 109-113.
27. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 2001; 239: 199-207.
28. Ramm GA, Shepherd RW, Hoskins AC etal. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 2009; 49: 533-544.
29. Tesch GH. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008; 294: F697-701.
30. Sun L, Louie MC, Vannella KM etal. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 2011; 300: L341-353.
31. Xia Y, Frangogiannis NG. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets 2007; 6: 101-107.
32. Chong RS, Jiang YZ, Boey PY etal. Tear cytokine profile in medicated glaucoma patients effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome. Ophthalmology 2010; 117: 2353-2358.
33. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 2002; 134: 481-498.